Unknown

Dataset Information

0

Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach

ABSTRACT:

SUBMITTER: Choudhury A 

PROVIDER: S-EPMC7996102 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approach.
| S-EPMC12266346 | biostudies-literature
Unknown Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an <i>in-silico</i> approach.
| S-EPMC7544969 | biostudies-literature
Unknown Exploring SARS-COV-2 structural proteins to design a multi-epitope vaccine using immunoinformatics approach: An in silico study.
| S-EPMC8055380 | biostudies-literature
Unknown Inhibitory efficacy of 2, 4-diacetylphloroglucinol against SARS-COV-2 proteins: in silico study.
| S-EPMC8800849 | biostudies-literature
Unknown Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis.
| S-EPMC7457603 | biostudies-literature
Unknown Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach.
| S-EPMC10141836 | biostudies-literature
Unknown Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach.
| S-EPMC8373590 | biostudies-literature
Unknown Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach.
| S-EPMC8971047 | biostudies-literature
Unknown SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.
| S-EPMC8293742 | biostudies-literature
Unknown In Silico Study of Mutational Stability of SARS-CoV-2 Proteins.
| S-EPMC8061876 | biostudies-literature